SUSTAINED PROPRANOLOL DELIVERY AND INCREASED ORAL BIOAVAILABILITY IN DOGS GIVEN A PROPRANOLOL LAURATE SALT

被引：19

作者：

AUNGST, BJ

HUSSAIN, MA

机构：

[1] Du Pont Merck Pharmaceutical Company, Wilmington, DE 19880-0400

来源：

PHARMACEUTICAL RESEARCH | 1992年 / 9卷 / 11期

关键词：

PROPRANOLOL; BIOAVAILABILITY; FIRST-PASS METABOLISM; SUSTAINED-RELEASE; ABSORPTION;

D O I：

10.1023/A:1015831517800

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

[No abstract available]

引用

页码：1507 / 1509

页数：3

共 20 条

[1]

INUI K, 1974, CHEM PHARM BULL, V22, P1781

[2] ENHANCEMENT OF JEJUNAL AND COLONIC ABSORPTION OF FOSFOMYCIN BY PROMOTERS IN THE RAT [J].

ISHIZAWA, T ;

HAYASHI, M ;

AWAZU, S .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1987, 39 (11) :892-895

[3]

LO MW, 1982, J PHARMACOL EXP THER, V221, P512

[4] AN AUTOMATED HPLC METHOD FOR THE ASSAY OF PROPRANOLOL AND ITS BASIC METABOLITES IN PLASMA AND URINE [J].

LO, MW ;

SILBER, B ;

RIEGELMAN, S .

JOURNAL OF CHROMATOGRAPHIC SCIENCE, 1982, 20 (03) :126-131

[5]

MELANDER A, 1977, CLIN PHARMACOL THER, V22, P108

[6] EFFECT OF OLEIC-ACID VESICLES ON INTESTINAL-ABSORPTION OF CARBOXYFLUORESCEIN IN RATS [J].

MURAKAMI, M ;

YOSHIKAWA, H ;

TAKADA, K ;

MURANISHI, S .

PHARMACEUTICAL RESEARCH, 1986, 3 (01) :35-40

[7] MODIFICATION OF INTESTINAL-ABSORPTION OF DRUGS BY LIPOIDAL ADJUVANTS [J].

MURANISHI, S .

PHARMACEUTICAL RESEARCH, 1985, (03) :108-118

[8] PHARMACOKINETICS OF LONG-ACTING PROPRANOLOL - IMPLICATIONS FOR THERAPEUTIC USE [J].

NACE, GS ;

WOOD, AJJ .

CLINICAL PHARMACOKINETICS, 1987, 13 (01) :51-64

[9] MECHANISM FOR THE ENHANCEMENT EFFECT OF FATTY-ACIDS ON THE PERCUTANEOUS-ABSORPTION OF PROPRANOLOL [J].

OGISO, T ;

SHINTANI, M .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (12) :1065-1071

[10] THE ORAL ABSORPTION OF CEFOXITIN FROM OIL AND EMULSION VEHICLES IN RATS [J].

PALIN, KJ ;

PHILLIPS, AJ ;

NING, A .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 33 (1-3) :99-104

← 1 2 →